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Abstract
There are three pathways in tryptophan (TRP) metabolism. Serotonin (5-hydroxytryp-
tamine; 5-HT) pathway is important in mood, anxiety, memory, and cognition and is 
impaired in depression. Kynurenine (KYN) pathways are involved in immunity, inflam-
mation, muscles movement, and mental health. We investigated changes in TRP metabo-
lites in plasmas of stressed rats and in depressive patients. TRP metabolite levels in 5-HT 
and KYN pathways in various brain areas and plasma were increased soon after electric 
foot shock given to rats but returned to normal 24 h later. Plasma levels of 5-HT were very 
low or undetectable in patients of monopolar depression. 5-hydroxyindole acetic acid 
(5-HIAA)/TRP ratios or KYN/TRP ratios were not different between healthy controls and 
depressive patients, indicating 5-HT quickly being degraded into 5-HIAA in patients of 
depression but KYN levels were not changed in depression. These results indicate that 
TRP metabolism changes upon stress application and in patients of depression.
Keywords: tryptophan, serotonin, 5-hydroxyindole acetic acid, kynurenine, 
3-hydroxykynurenine, kynurenic acid
1. Introduction
Tryptophan (TRP) is one of the essential amino acids, which must be taken as food. It is not 
only needed for protein synthesis but serves as a substrate for bioactive component with 
important physiological roles.
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There are three pathways in TRP metabolism: serotonin (5-HT), kynurenine (KYN), and 
indole-3-acetic acid pathways.
Since 5-HT is known as an important neurotransmitter and derived from TRP, many people 
know about TRP to some extent. 5-HT is really involved in the adaptive responses in the 
central nervous system and considered to be related to mood, anxiety, or cognition [1].
5-HT is further converted in the pineal body and the retina to N-acetyl serotonin (NAS) and 
melatonin which controls circadian rhythm [2].
In mammals, most of the free TRP is converted to KYN and generates metabolites involved in 
inflammatory, immune, responses, and neurotransmission [3].
We have recently succeeded in simultaneous measurements of almost all TRP metabolites 
including melatonin by using an ultrahigh speed liquid chrom`atography and mass spec-
trometry (LC-MS) [4], which is the first time in the world.
In this chapter, we report about the precise methodology of the simultaneous measurements 
and some results obtained from stressed rats and depressive patients.
1.1. Measurements of TRP metabolites using LC-MS
1.1.1. Background
Since 5-HT and its derivatives have the strong fluorescence, high-sensitive analyses of some 
TRP metabolites can be performed by liquid chromatography with fluorescence detection. 
However, it is very limited to analyze the total metabolites including kynurenine by photo-
metric detection although kynurenic acid (KYNA) can be detected as zinc chelate compound 
under zinc acetate solution.
In the past years, liquid chromatograph mass spectrometry (LC-MS) has been widely spread 
in many areas including clinical and biological analyses. Since LC-MS with electrospray 
ionization (ESI) is suitable for determination of metabolites of TRP, LC-MS is expected as a 
powerful tool for this type of analysis.
In addition, the tandem mass spectrometer also has widely used in recent years with its high 
sensitivity and selectivity.
There are several researches for the simultaneous analyses of TRP metabolites using LC-MS or 
LC-MS/MS methods for clinical samples such as human serum and plasma [5, 6]. In general, 
isotope-labeled internal standards are used in LC-MS/MS analysis to improve the accuracy, 
although isotope-labeled regents are expensive and limited availability [7, 8]. Even though 
less accurate, acceptable results can be obtained without internal standards for the screen-
ing purposes. In this chapter, the simultaneous determination of TRP metabolites in human 
plasma by LC-MS/MS technique combined with simple pretreatment procedure is described.
1.1.2. Regents and instrumentation
The simultaneous analytical method was developed for major metabolites of TRP including 
melatonin.
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The targets are 17 of major metabolites, tryptophan (TRP), L-5-hydroxytryptophan (5-HTP), 
serotonin (5-HT), kynurenine (KYN), 5-hydroxy-tryptophol, tryptophol, 5-hydroxyindoleacetic 
acid (5-HIAA), indole-3-acetic acid, anthranilic acid (AA), kynurenic acid (KYNA), quinaldic 
acid, 3-indolebutyric acid, 3-hydroxykynurenine (3-HKYN), 3-hydroxyanthranilic acid (3-HAA), 
xanthurenic acid (XA), melatonin, and quinolinic acid (QA). Each compound is commercially 
available from major chemical regent manufacturers, such as Fujifilm-Wako chemical (Osaka, 
Japan) and Sigma-Aldrich (St. Louis, MO, USA).
Analysis was performed by a liquid chromatograph tandem mass spectrometer, the LCMS-
8060 mass spectrometer equipped with Nexera X2 liquid chromatograph system (Shimadzu 
Corporation, Kyoto, Japan).
The targets are separated by reversed phase mode using ODS analytical column, L-Columns 
ODS (2.1 mm x 150 mm, CERI, Tokyo, Japan) with a gradient elution. Mobile phases were 0.1% 
formic acid solution and acetonitrile with 5% concentration of acetonitrile to 3 min, then 5–95% 
in 6 min followed by 5% in 3 min (12 min analytical cycle) at total flow rate of 0.4 mL/min. The 
Qualification (m/z) Qualification (m/z)
Compound Molecular 
weight
Monoisotopic 
mass
Precursorion Production Precursorion Production
DL-Trypotophan 204.225 204.090 205.10 188.10 205.10 146.10
L-5-
Hydroxytrypotophan
220.225 220.085 221.10 204.05 221.10 162.00
Serotonin 176.215 176.095 177.10 160.10 177.10 115.05
L-Kynurenine 208.214 208.085 209.10 192.00 209.10 94.05
5-Hydroxytrypotophol 177.200 177.079 178.10 160.10 178.10 115.05
Trypotophol 161.200 161.084 162.10 144.05 162.10 117.10
5-Hydroxyindole 
-3-acetic acid
190.176 190.051 192.10 146.05 192.10 110.00
Indole-3-acetic acid 175.184 175.063 176.10 130.05 176.10 77.05
Anthranilic acid 136.129 136.040 138.10 120.05 138.10 65.05
Kynurenic acid 189.167 189.043 190.10 144.05 190.10 89.10
Quinaldic acid 172.161 172.040 174.10 128.05 174.10 156.05
Indole-3-acetic acid 202.230 202.087 204.10 186.10 204.10 130.10
3-Hydroxykynurenine 224.213 224.080 225.15 208.20 225.15 162.15
Hydroxyanthranilic 
acid
152.128 152.035 154.15 136.20 154.15 80.15
Xanthurenic acid 205.167 205.038 206.15 160.20 206.15 132.20
Melatonin 232.279 232.121 232.20 174.10 232.20 130.05
Quinolinic acid 167.120 167.022 168.00 78.10 168.00 150.00
Table 1. MRM transition.
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Figure 1. The procedure of deproteinization.
temperature of the column was 40°C. For LC-MS, electrospray ionization (ESI) was used with 
multi-reaction monitoring (MRM) mode.
Flow rate of the neutralizer and the drying gas were 2 L/min and 10 mL/min, respectively. 
The temperature of desolvation line (heated capitally tube) was 250°C. ESI interface was used 
at 400°C with 10 L/min of heating gas flow. Each MRM transition was optimized using each 
standard solution. Optimized results are shown in Table 1.
All mother solution of 1 mg/mL had been stocked under −80°C and standard samples for 
calibration curve were prepared before use as mixture solution by consideration of each range 
of measurement concentration.
1.1.3. Analysis of human plasma
Aliquot of 50 μL human plasma was used for each sample analysis. The procedure including 
deproteinization is shown in Figure 1. The typical chromatograms of 17 major metabolites are 
shown in Figure 2 as standard solution and in Figure 3 as human plasma sample. These chro-
matograms demonstrate the usefulness of the developed method for simultaneous analysis 
of TRP metabolites.
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1.2. Stress and TRP metabolism
Stress influences many functions related to mental and body health. We have shown that the 
application of electric shock increased plasma and brain TRP, 5-HT, and 5-HIAA levels [9, 10] 
and changed nicotine-induced release of 5-HT or dopamine in rats [11–14]. We also examined 
changes in serotonergic and kynurenic pathways in rats exposed to foot shock [15].
Stress induces a number of changes in the central system of neurotransmitters, particularly 
noradrenaline and 5-HT [16, 17].
A pathologic overabundance of endogenous excitotoxin, quinolinic acid, or hypofunction of 
KYNA has been hypothetically linked to the occurrence of seizures and nerve cell death [18, 19].
Figure 2. Chromatograms of 17 major metabolites of tryptophan.
Figure 3. Chromatogram of human plasma sample.
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1.2.1. Stress and TRP metabolites in the brain
Animals: Male Wistar rats (9 weeks old) were fed with standard laboratory foods and tap water 
ad libitum. Two weeks later, rats were randomly divided into two groups. One group received 
foot shock, which was given as a series of 10-s shock (o.19 mA) followed by 50 s intervals dur-
ing a 60-min period. CT 110 cycle timer and NS-SG01 shock generator scrambler (Neuroscience 
Inc., Tokyo, Japan) were used. Samples of 10 rats were taken immediately after the foot shock 
and samples of another 10 rats were taken 24 h after the shock. Ten rats were used as controls.
Blood: Rats were anesthetized with pentobarbital, and blood was taken by heart puncture 
and put into a tube containing 3/13% sodium citrate. Plasma was obtained by centrifugation 
at 3000 rpm for 20 min.
Brain sampling: The brains were removed and chilled on ice. Eight regions (cerebellum, 
medulla, hypothalamus, striatum, midbrain, hippocampus, cortex, and frontal cortex) were 
dissected and samples were immediately frozen. Frozen brain samples were homogenized 
in 0.15 N perchloric acid containing 0.025% EDTA (pH 3.0). The samples were centrifuged 
at 14,000 rpm for 20 min at 4°C. After centrifugation, the supernatant was filtered (0.45 μm 
Millipore filter) and stored at −80°C until assayed.
Figure 4 shows TRP pathway and its metabolites.
Figure 5 shows that 5-HT levels increased significantly at hypothalamus and midbrain soon 
after the shock but returned normal 24 h later.
5-HT levels were not increased in cerebellum, medulla, striatum, hippocampus, cortex, and 
frontal cortex.
Figure 6 shows 5-HIAA levels of various brain areas after foot shock.
5-HIAA levels significantly increased in all the brain areas except striatum but returned nor-
mal 24 h later.
Figure 7 shows KYN levels in various brain areas after foot shock.
KYN levels significantly increased in all the brain areas after foot shock but returned to nor-
mal 24 h later.
Figure 8 shows plasma levels of TRP, 5-HT and 5-HIAA after foot shock.
Plasma levels of TRP, 5-HT, and 5-HIAA significantly increased after foot shock but returned 
to normal 24 h later.
Figure 9 shows plasma levels of KYN,3-HKYN, and KYNA after foot shock.
Plasma levels of KYN, 3-HKYN, and KYNA increased significantly after foot shock but 
returned to normal 24 h later.
1.3. TRP metabolites in plasma of patients of depression
We asked male and female acquaintances older than 50 years old and male and female 
college students to participate in the experiments. We checked their health carefully and 
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recruited them if there were no health problems such as diabetes, hypertension, or no seri-
ous diseases experienced in the past. They did not smoke in the past. We also excluded 
people who took drugs for dyslipidemia, hyperglycemia, or hypertension. We collected 
blood samples early morning. Participants were asked not to eat anything after 21.00 PM 
the previous evening. Plasma specimens were collected for assays of blood parameters. We 
obtained an informed consent prior to conducting the protocol which had been approved 
by the Ethical Committee of Showa Women’s University and Yokohama North Hospital of 
Showa University.
Patients were diagnosed to be monopolar depression at the psychiatry clinic of Yokohama 
North Hospital of Showa University. The Zung Self-Rating Depression Scale [20] was used, 
which is a short self-administered survey to quantify the depressed status of a patient. There 
are 20 items on the scale that rate the affective, psychological, and somatic symptoms associ-
ated with depression. We took blood from five male patients (26, 30, 45, 47, and 56 years old) 
and four female patients (23, 25, 41, and 60 years old).
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Figure 5. Serotonin (5-HT) levels in various brain areas after electric foot shock. con, control; E0, soon after the shock; E1, 
24 h after the shock. *p < 0.05 and **p < 0.01.
Figure 6. 5-HIAA levels in various brain areas after foot shock. con, control; E0, soon after the shock; E1, 24 h after the 
shock. *p < 0.05.
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5-HT was detected only in plasma of two patients. Both of them were young females. A 60-year-
old woman took Jay Zoloft 25 mg and ethyl loflazepate 1 mg, and another 41-year-old woman 
took Cymbalta 20 mg and Luran 3 mg. 5-HT was not detected in plasmas of these women.
The number of healthy old men and young women were 20, and the number of depressive 
patients were 9.
Figure 7. Kynurenine levels in various brain areas after foot shock. con, control; E0, soon after the shock; E1, 24 h after 
the shock. **p < 0.01 and ***p < 0.001.
Figure 8. Plasma levels of TRP, 5-HT, and 5-HIAA after electric foot shock. con, control; E0, soon after the shock; E1, 24 h 
after the shock. *p < 0.05 and **p < 0.01.
Measurement of Plasma Tryptophan Metabolites: Clinical and Experimental Application… 9
Figure 9. Plasma levels of KYN (kynurenine), 3-HKYN (3-hydroxykynurenine), and KYNA (kynurenic acid). con, 
control; E0, soon after the shock; E1, 24 h after the shock. **p < 0.01 and ***p < 0.001.
Young men (n = 20) Young women (n = 20) Old men (n = 20)
Age 20.7 ± 1.5 21.2 ± 0.7 60.8 ± 9.9
Height (m) 1.72 ± 0.06 1.58 ± 0.05 1.69 ± 0.07
Weight (kg) 65.1 ± 8.9 51.4 ± 5.8 71.1 ± 13.1
BMI 22.1 ± 3.1 20.4 ± 1.6 24.9 ± 3.7
Table 2. Basic backgrounds of healthy participants.
Patients Sex Serotonin detection Visit (age) Medication
H1 Male — 45 None
H2 Male — 47 None
H3 Female — 60 Jay Zoloft 25 mg, ethyl 
loflazepate1 mg
H4 Female + 23 None
H5 Female + 25 None
H6 Male — 30 None
H7 Female — 41 Cymbalta 20 mg, Luran 3 mg
H8 Male — 56 None
H9 Male — 26 None
Table 3. Various parameters of patients.
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Tables 2 and 3 show the background data of these patients.
Figure 10 shows plasma  levels of 5-HT of healthy young women, old men and depressive patients.
Plasma levels of 5-HT in depressive patients were very low compared to those of old men and 
young women. 5-HT was detected in plasmas of only two young females.
Figure 11 shows 5-HT/TRP and 5-HIAA/TRP ratios.
Although 5-HT/TRP ratio of depressive patients was low compared to that of old men and 
young women, 5-HIAA/TRP ratio was almost the same as that of old men and young women.
Figure 10. 5-HT levels in plasmas of depressive patients and controls.
Figure 11. 5-HT or 5-HIAA/TRP ratio.
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Figure 12 shows that there were no differences in KYN/TRP ratios between that of old men, 
young women, and depressive patients.
2. Discussion
As stated above, most of the metabolites of KYN pathway are found in the brain [1, 21–23]. 
Some metabolites of KYN pathway are neurotoxic and some are neuroprotective.
KYNA is an endogenous neuroprotective agent that is usually present in the brain at nanomo-
lar concentration [24]. KYNA is an antagonist to quinolinic acid (QA) and acts on the glycine 
modulatory site of the NMDA receptor at low concentration [22] and at higher concentration 
at the glutamate site of the NMDA receptors and also on the a-amino3-hydroxy-5-methyl-
4-isoxazolepropionate (AMPA) receptors [25]. It also antagonizes the alpha 7 nicotinic acetyl-
choline receptors [26] and selectively activates a G-protein-coupled receptor, GPR35–48 [27]. 
Many neuroactive intermediates are shown in KYN pathways [28]. So, we decided to measure 
some of TRP metabolites in the brain and plasma in the stressed rats.
Our results show that 5-HT levels increased only in hypothalamus and midbrain, but its deg-
radation product, 5-HIAA levels, increased in every part of the brain. These results may imply 
that 5-HT is quickly converted to 5-HIAA soon after shock, so that 5-HT levels apparently 
did not increase after shock. This finding is important in the explanation of plasma 5-HT and 
5-HIAA levels in patients of depression.
Figure 12. KYN/TRP ratio.
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Some of TRP metabolites were shown to be neuroexcitatory and convulsive, thus toxic [29]. 
One of such neuroexcitatory factors in KYN pathway is 3-HKYN [24]. Its synthesis is cata-
lyzed by kynurenine 3-hydroxylase. Although data of brain analyses were not shown here, 
3-HKYN levels increased in all the brain areas and plasma (Figure 6).
3-HKYN is said to be the most toxic substance in TRP metabolism [30]. So stress induces 
disturbances in the central nervous system by increasing levels of 3-HKYN (Figures 4–9).
KYN is usually hydroxylated to 3-HKYN and then further converted to 3-hydroxyanthranilic acid 
(3-HAA). 3-HAA is rapidly converted to QN by the non-enzymatic reaction and further to NAD+.
The other pathway of KYN, the production of KYNA and xanthurenic acid (XA), is minor 
under normal conditions. KYNA is an endogenous antagonist of excitatory amino acid recep-
tors and may serve as a modulator of excitatory nerve transmission. This study may suggest 
that stress induces the indirect modulation of excitatory amino acids in the central nervous 
system by increasing KYNA.
KYNA has an antagonist activity of the three ionotropic excitatory amino acid receptors [22, 
31]. At low concentrations, KYNA blocks the glycine co-agonist site of N-methyl-D-aspartate 
receptor and may serve to prevent the overactivation of glutamic acid receptor. When brain 
kynurenic acid levels were increased experimentally, neuroprotection and seizure reduction 
have been reported [32].
The roles of various metabolites of KYN pathway are reviewed [28], so we do not discuss 
these roles in detail.
As to relationships between serotonin levels and depression, we analyzed plasma levels of 
TRP metabolites in patients of depression.
Although the concentration of 5-HT has been considered to be low in depressive patients 
[33], 5-HT concentration in the brains of suicide victims was not low [34]. Therefore, it is not 
known if 5-HT concentration is decreased in the brains of depressive patients (Table 2).
We decided to measure TRP metabolites in patients of monopolar depression. Table 3 shows 
five male patients participated in the experiments. The age is 44–61 years old (41.2 ± 11.3). 
Plasma serotonin levels were detected only in two young female patients. We could not mea-
sure 5-HT in plasma in seven persons, which is shown in Figure 10.
Although plasma serotonin levels and 5-HT/TRP ratio were low in depressive patients, the 
levels of 5-HIAA/TRP were not lower in depressive patients. This result indicates that 5-HT 
is degraded to 5-HIAA in depressive patients almost to the same extent to healthy old and 
young women (Figures 11 and 12).
We measured the levels of KYN in healthy old men and young women and depressive patients. 
TRP seems to be degraded to KYN pathways to the same extent in these three groups.
These results suggest that in depressive patients 5-HT was quickly degraded to 5-HIAA, and 
this seems to be a reason of low 5-HT levels in depressive patients.
As to a relationship between serotonin pathway and KYN pathway, Lapin IP suggested 
that in depression tryptophan 2,3-dioxygenase in the liver shunted metabolism of serotonin 
away from 5-HT production to KYN production, resulting in serotonin deficiency [35]. KYN, 
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QN, and 3-HKYN were shown to be anxiogenic and KYNA were anxiolytic [36]. From these 
results, he tried to explain the effects of antidepressive drugs.
Our results do not support this hypothesis. Metabolites of KYN pathways were not high in 
depressive patients.
There have not been enough studies as to 5-HT levels in the brain of patients of bipolar depres-
sion. Serotonin levels in cerebrospinal fluids of patients of bipolar depression were shown to 
be high [37] or normal [38]. So it seems to be very important to discriminate monopolar and 
bipolar depression to study roles of serotonin in the pathogenesis of disease.
Our results show that plasma 5-HT levels were low and metabolites of KYN pathway were 
not changed in patients of monopolar depression.
3. Statistics
Standard ANOVA methodology was used and p < 0.05 was considered as significant differ-
ence. Results are expressed as mean ± SD. Bars of figures represent standard deviations.
4. Ethics
This work has been approved by the Ethical committees of Showa Women’s University, Showa 
University School of Medicine, and NPO “International projects on food and health” and has 
been carried out in accordance with The Code of Ethics of the World Medical Association 
(Declaration of Helsinki) for experiments.
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